Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Improved antigen response to conjugate vaccine in mature vs. neonatal mice

April 26, 1999

IDEC-131, an inhibitor of B-cell activation for the treatment of autoimmune disorders

April 23, 1999

GPC and MorphoSys collaborate on human therapeutic antibody program

April 23, 1999

Inhibitors of PTKs and T-cell activation/proliferation in development at BMS

April 22, 1999

Belgian research team designs potent, irreversible and stable DPP IV inhibitors

April 21, 1999

Rodent and early human studies support feasibility of transcutaneous immunization

April 21, 1999

First CpG DNA-based immunotherapeutic enters human trials

April 20, 1999

Potential C. albicans vaccine tested in mice

April 20, 1999

Immune Response describes herpes vaccine research at FASEB 99

April 19, 1999

Compounds and methods for treating or diagnosing leishmaniasis disclosed by Corixa

April 16, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...